The group runs AMG's high-throughput sequencing core facility, which sequences samples from all over Norway (over 15,000 samples in 2023), and specializes in handling low-input samples. In addition, the group are early adopters of new genomic technologies such as optical genome mapping and long-read sequencing. Research projects in the group apply these new technologies to tricky and unsolved genetic diagnoses. The group therefore works tightly with clinical geneticists to solve cases where regular diagnostic procedures have been unsuccessful.

Photos: Bård Gudim AS

• DETECT study: Detection of structural genomic variants causing hereditary cancer (Norwegian Cancer Society project #281610): Millionsatsing på dristig kreftforskning (kreftforeningen.no)
• Norwegian Sequencing Centre (www.sequencing.uio.no)
• Long-read DNA sequencing with oxford Nanopore technology (Oxford Nanopore Technologies)
• Structural Variant Detection with Bionano optical genome mapping (Bionano Genomics | Structural Variation Detection with Optical Genome Mapping)
• Functional assay of FBN1 secretion (together with Benedicte Paus, OUH - Group members (ous-research.no)

Contact information

Gregor Gilfillan - gregorg@medisin.uio.no
Visiting /postal address: Dept. Medical Genetics, Building 25, 2nd floor (North), Ullevål Hospital, Kirkeveien 166, 0450 Oslo

Contact information

Gregor Gilfillan - gregorg@medisin.uio.no
Visiting /postal address: Dept. Medical Genetics, Building 25, 2nd floor (North), Ullevål Hospital, Kirkeveien 166, 0450 Oslo